Feds Still Investigating Whether Biomet Broke Rules Abroad

By Adam Sege (March 29, 2016, 7:52 PM EDT) -- The U.S. Department of Justice and the U.S. Securities and Exchange Commission are continuing to investigate "alleged improprieties" by medical device company Biomet Inc. in Brazil and Mexico to determine whether the company breached an agreement with the government that followed a prior foreign bribery investigation, according to an SEC filing....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!